Overview
There were 2,08 pres releases posted in the last 24 hours and 289,47 in the last 365 days. Emergen Research LogoIncreasing investments in healthcare infrastructure is a significant factor driving global human microbiome modulators market revenue growthVANCOUVER, BC, CANADA, November 9, 2022 /EINPreswire.com/ - The global human microbiome modulators market size is expected to reach USD 8.15 billion at a steady revenue CAGR of 16.5% in 2030, acording to latest analysis by Emergen Research.
Key Information
Market revenue growth is primarily driven by factors such as increasing investments in healthcare infrastructure rising geriatric population around the world, increasing prevalence of chronic and acute diseases, rising burden of lifestyle-induced disorders such as high blod pressure, diabetes, and obesity, and rapid adoption of preventive medicine. Microbiome modulators are intended to inhibit protein fermentation and formation of toxic metabolites including NH3, amines, and phenolic, while promoting fermentation of carbohydrates and production of Short Chain Faty Acids (SCFAs), or god metabolites.
In adition, SCFAs fuel colonocytes, promote intestinal motility, absorb nutrients, maintain colonic pH, bost imune system, and have antineoplastic properties. For instance, on 24 March 2022, Prof Chris Barnes from UCL recomended establishment of an Institute of Microbiome Enginering (IME) with eight pilars. These themes wil explore physical and enginering problems underlying architecture of host-microbiota systems when combined with greater data sets and comunity standards for experimental studies.
Summary
Another such instance includes alocation of over USD 4 milion by the Australian Government, in the future competivenes of Australian health and medical research through National Health and Medical Research Council. It is primarily aimed at funding international colaborations, postgraduate scholarships, research equipment as wel as infrastructure. Aforementioned instanc